Systematic Multi-Trait AAV Capsid Engineering for Efficient Gene Delivery (Eid et al., Nature Communications, 2024)
-
Updated
Aug 26, 2024 - Jupyter Notebook
#
aav
Here are 15 public repositories matching this topic...
Open-source mechanistic model for ion exchange chromatography
chemical-engineering manufacturing chromatography biotechnology aav downstream gene-therapy protein-simulations biopharma ion-exchange
-
Updated
May 28, 2025 - Jupyter Notebook
Autonomous Aerial Vehicle
agent machine-learning reinforcement-learning drone quadcopter machine-learning-algorithms ml planning reinforcement-learning-algorithms rl reinforcement reinforcement-agents reinforcement-learning-agent reinforcement-learning-playground aav
-
Updated
May 9, 2019 - C#
SSV-Conta quantify and characterize DNA contaminants from gene therapy vector sequenced by Illumina system.
-
Updated
May 5, 2020
Prioritise cell-type-specific gene targets from the Rare Disease Celltyping project.
-
Updated
Mar 21, 2024 - HTML
Securing a Web Application :: Learn how to use NetLicensing with Java and Spring Security.
-
Updated
Nov 12, 2020 - Java
A GLUE project for comparative genomic analysis of parvoviruses
reproducible-research glue open-science comparative-genomics aav gene-therapy virus-evolution paleovirology parvovirus
-
Updated
Jan 22, 2026 - JavaScript
Labs64 NetLicensing / Auth0 Integration
-
Updated
Mar 22, 2021 - JavaScript
Benchmark-validated chimeric read detection for AAV vectors on Oxford Nanopore. F1 0.973 with zero false positives, measured against a ground-truth read simulator.
python bioinformatics quality-control nanopore genomics oxford-nanopore aav long-read-sequencing gene-therapy chimeric-reads
-
Updated
Jul 24, 2026 - Python
An open-source Python adaptation of the MIT mechanistic model for recombinant AAV production via triple transfection of HEK293 cells (Nguyen et al., 2021). Includes a framework for adaptation to external data..
-
Updated
Jun 22, 2026 - Jupyter Notebook
Affinia Therapeutics is a clinical-stage biotechnology company in Waltham, Massachusetts pioneering next-generation adeno-associated virus (AAV) gene therapies. Using AI and structural modeling to rationally design novel capsids that better target tissues for improved safety and effectiveness, Affinia develops therapeutic cargoes for devastating…
company life-sciences biotechnology cardiology pharmaceuticals aav rare-disease gene-therapy apis-json clinical-stage
-
Updated
Aug 2, 2026
CpG-depleted, codon-optimised FST344 follistatin sequences for AAV gene therapy. AlphaFold3 validated.
bioinformatics structural-biology computational-biology molecular-biology longevity sequence-analysis protein-engineering codon-optimization aav gene-therapy alphafold gene-sequence sarcopenia follistatin fst344 gene-optimization cpg-depletion muscle-wasting myostatin
-
Updated
Mar 30, 2026 - HTML
Ascend Advanced Therapies is a gene-to-GMP contract development and manufacturing organization (CDMO) for advanced therapies, specializing in adeno-associated virus (AAV) vector development and manufacture for gene therapies, immunotherapies, oncolytics, and vaccines.
company life-sciences biotechnology pharmaceuticals aav gene-therapy apis-json cell-therapy cdmo contract-manufacturing
-
Updated
Aug 2, 2026
Mechanistic translational PK/biodistribution model for intrathecal AAV gene therapy (mouse→NHP→human): cross-species dose translation, DRG safety, Bayesian dose updating, V&V, and an interactive app.
-
Updated
Jun 9, 2026 - Python
Dyno Therapeutics is an AI-driven biotechnology company in Watertown, Massachusetts that combines machine learning with high-throughput in vivo experimentation to engineer adeno-associated virus (AAV) vectors for gene therapy.
machine-learning company drug-discovery life-sciences protein-design biotechnology aav gene-therapy apis-json
-
Updated
Aug 2, 2026
Improve this page
Add a description, image, and links to the aav topic page so that developers can more easily learn about it.
Add this topic to your repo
To associate your repository with the aav topic, visit your repo's landing page and select "manage topics."